How Can You Tell If You Are Diabetic: Signs & Tests

Diabetes often announces itself through a handful of recognizable symptoms: frequent urination, persistent thirst, unexplained weight loss, and fatigue that does not improve with rest. But many people with type 2 diabetes have no obvious symptoms at all, which is why blood tests remain the only reliable way to confirm the diagnosis. The standard tests measure blood sugar at different time points, and each has strengths and blind spots worth understanding before you walk into a lab.

The Classic Warning Signs

The symptoms most people associate with diabetes are driven by high blood sugar overwhelming the body’s ability to process it. When glucose builds up in the bloodstream, your kidneys work harder to filter it out, pulling extra water along with it. That leads to frequent urination, which in turn makes you dehydrated and thirsty. Because your cells are not absorbing glucose efficiently, your body breaks down fat and muscle for energy instead, causing weight loss even if your appetite is normal or increased. Blurred vision, slow-healing cuts, and recurring infections (especially yeast infections or urinary tract infections) round out the list.

These symptoms tend to appear more suddenly and severely in type 1 diabetes, where insulin production drops off sharply. In type 2, blood sugar creeps up over months or years, and you can adapt to it without realizing anything is wrong. That slow creep is exactly why relying on symptoms alone is a poor strategy for catching diabetes early.

Signs You Might Not Expect

Beyond the classic red flags, diabetes leaves subtler traces on the body that you or your doctor might overlook. Skin changes are among the most visible. Darkened, velvety patches of skin on the neck, armpits, or groin, a condition called acanthosis nigricans, strongly correlate with insulin resistance. Dry, itchy skin, small round scaly patches on the shins (sometimes called diabetic dermopathy), and waxy, discolored patches on the lower legs are all linked to the metabolic disruption that diabetes causes.1Journal of Education, Health and Sport. The Skin as a Window to Diabetes Mellitus: Manifestations, Complications and Clinical Insights These are not just cosmetic annoyances. They can be early clues that blood sugar is off, sometimes appearing before a formal diagnosis.

Vision changes are another underappreciated signal. Fluctuating blood sugar can temporarily alter the shape of your eye’s lens, causing your prescription to seem wrong from one week to the next. Some people become more nearsighted; others shift in the opposite direction. These refractive changes can actually be the first sign of diabetes, distinct from the long-term retina damage that develops later.2PubMed Central. Refractive Changes Associated with Diabetes Mellitus If your eyeglass prescription keeps changing without explanation, it is worth asking your doctor about a blood sugar check.

Nerve damage is perhaps the trickiest early sign. You might expect diabetes-related neuropathy to hurt, and sometimes it does, with burning, tingling, or shooting pains in the feet. But painless neuropathy is common and represents a real diagnostic challenge because it often goes unnoticed until irreversible nerve damage has occurred.3PubMed Central. Painful and non-painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues A gradual loss of sensation in your feet, difficulty feeling temperature changes, or stumbling more often can all be the quiet consequences of chronically elevated blood sugar.

The Standard Blood Tests

If symptoms or risk factors raise suspicion, a handful of blood tests can confirm or rule out diabetes. Each measures something slightly different, and no single test is perfect.

  • Fasting plasma glucose (FPG): You fast overnight, then have your blood drawn. A result of 126 mg/dL or higher on two separate occasions indicates diabetes. Values between 100 and 125 mg/dL fall into the prediabetes range.
  • Oral glucose tolerance test (OGTT): After fasting, you drink a sugary solution and have your blood tested two hours later. A reading of 200 mg/dL or higher means diabetes; 140 to 199 mg/dL signals prediabetes.
  • HbA1c (glycated hemoglobin): This measures your average blood sugar over roughly two to three months. An HbA1c of 6.5% or higher indicates diabetes, and values between 5.7% and 6.4% suggest prediabetes.4ScienceDirect / European Journal of Internal Medicine. The oral glucose tolerance test (OGTT) revisited
  • Random plasma glucose: A blood sugar reading taken at any time, regardless of when you last ate. A level of 200 mg/dL or above, combined with symptoms, is considered diagnostic.5PubMed. Tests of glycemia for the diagnosis of type 2 diabetes mellitus

These tests do not always agree with each other. In one study of a general population, HbA1c picked up about 70% of newly diagnosed diabetes cases, the OGTT caught roughly 64%, and fasting glucose alone detected only about 43%.6PubMed Central. Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test Fasting glucose is the simplest test but also the least sensitive on its own, meaning it misses more cases. HbA1c is convenient because it does not require fasting, but it has its own limitations, which deserve a closer look.

Even a casual blood sugar reading can carry useful information. Research has shown that having two random plasma glucose results of 130 mg/dL or higher within the same year predicted a diabetes diagnosis with about 93% specificity, meaning very few false alarms.7PLoS ONE. Random plasma glucose predicts the diagnosis of diabetes If you have had elevated readings on routine bloodwork, that is a strong signal to get formal follow-up testing even if you feel fine.

When HbA1c Can Mislead

HbA1c is widely used because it is easy and reflects a longer time window than a single glucose snapshot. But it measures how much sugar has attached to your red blood cells, so anything that changes red blood cell turnover can throw the number off. Conditions like iron-deficiency anemia, sickle cell trait, and recent blood transfusions can all distort the result.

Race and ethnicity add another layer of complexity. Studies have documented that Black individuals tend to have higher HbA1c values relative to their actual average blood glucose compared with white individuals, even after adjusting for other factors. People with this kind of mismatch between HbA1c and glucose readings are at risk of being overdiagnosed when HbA1c is used alone. In one analysis, participants with high mismatches were classified as having prediabetes or diabetes at far higher rates by HbA1c criteria than by glucose-based criteria, while those with low mismatches were mostly classified as normal by HbA1c but could actually have glucose-defined diabetes that went undetected.8PubMed. Impact of mismatches in HbA(1c) vs glucose values on the diagnostic classification of diabetes and prediabetes Research on this discrepancy has led some experts to caution that relying on HbA1c as the sole diagnostic criterion creates the potential for systematic misclassification across racial and ethnic groups.9The Journal of Clinical Endocrinology & Metabolism. Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes

The practical takeaway: if your HbA1c result is borderline or does not match what your daily glucose readings suggest, a follow-up fasting glucose or OGTT can clarify the picture. This is especially relevant if you are Black, have a hemoglobin variant, or have any condition that affects red blood cell lifespan.

Who Should Get Screened and When

You do not have to wait for symptoms to get tested. The U.S. Preventive Services Task Force recommends that asymptomatic adults aged 35 to 70 who are overweight or obese get screened for prediabetes and diabetes, and it suggests considering earlier screening in racial and ethnic groups that face higher risk at younger ages or lower body weights.10PubMed Central. Screening for Prediabetes and Diabetes: Clinical Performance and Implications for Health Equity The American Diabetes Association casts a wider net, recommending screening for any adult under 45 who has a BMI of 25 or higher and at least one additional risk factor, and for everyone 45 and older regardless of weight.11PubMed Central. Reconsidering the Age Thresholds for Type 2 Diabetes Screening in the U.S

Risk factors that should move you toward earlier or more frequent screening include a family history of type 2 diabetes, a personal history of gestational diabetes, polycystic ovary syndrome, a sedentary lifestyle, and belonging to a population with elevated risk (including Black, Hispanic, Native American, Asian American, and Pacific Islander backgrounds). If you have been told you have prediabetes, repeat testing every one to three years makes sense because the progression rate is high.

Gestational Diabetes Testing

Pregnancy changes how your body handles sugar, and gestational diabetes can develop even in women with no prior history of blood sugar problems. Most guidelines recommend screening between 24 and 28 weeks of pregnancy using a 75-gram OGTT, which measures fasting glucose, one-hour glucose, and two-hour glucose after drinking the sugary solution. An abnormal value at any of those three time points is enough for a diagnosis.12PubMed Central. Gestational Diabetes Mellitus Subtypes Classified by Oral Glucose Tolerance Test and Maternal and Perinatal Outcomes

Some centers use a simplified screening approach where a fasting glucose is drawn first, and only women with borderline fasting values proceed to the full OGTT.13PubMed. Simplified gestational diabetes screening with a triaging fasting plasma glucose reduces the burden of oral glucose tolerance tests during pregnancy This reduces unnecessary testing for women whose fasting glucose is clearly normal or clearly elevated. Either way, gestational diabetes usually resolves after delivery, but it sharply increases the mother’s lifetime risk of developing type 2 diabetes later, making postpartum follow-up important.

Telling Type 1 from Type 2

Once diabetes is confirmed, knowing which type you have changes everything about treatment. In most cases the distinction is obvious from the clinical picture: type 1 typically shows up in children or young adults with sudden symptoms and rapid weight loss, while type 2 develops gradually in older, often overweight adults. But the lines blur more often than people realize. A slow-onset autoimmune form called latent autoimmune diabetes in adults (LADA) looks like type 2 at first but eventually requires insulin, and some people with type 2 present at a young age.

Two lab tools help clarify ambiguous cases. The first is autoantibody testing. Antibodies against specific proteins, particularly one called glutamic acid decarboxylase (GAD), are among the most reliable markers of autoimmune diabetes in both children and adults. They are currently the only biomarkers that can reliably distinguish LADA from type 2.14PubMed. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes Adding a newer antibody test for the zinc transporter 8 protein can improve detection of LADA even further.15PubMed. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus

The second tool is C-peptide measurement. C-peptide is released by the pancreas alongside insulin in equal amounts, so measuring it tells you how much insulin your body is still making on its own. A very low C-peptide level (below 0.2 nmol/L) is strongly associated with type 1 diabetes and points toward a need for insulin therapy, whereas a normal or high level suggests type 2, where the issue is more about insulin resistance than insulin absence.16PubMed Central. A Practical Review of C-Peptide Testing in Diabetes C-peptide levels can also help predict who will eventually need insulin and may correlate with the risk of certain complications.17PubMed Central. The clinical utility of C-peptide measurement in the care of patients with diabetes

Prediabetes and What Comes Next

A prediabetes diagnosis is not a polite warning you can safely ignore. In a large population-based study, about three out of four people diagnosed with prediabetes at age 45 eventually progressed to full diabetes over their remaining lifetime.18The Lancet Diabetes & Endocrinology. Lifetime risk, progression, and decades of life lost in type 2 diabetes in the Netherlands The same study found that people with severe obesity lived about a decade fewer years free of glucose problems compared with those at a normal weight. These are not abstract statistics; they translate into years of medication, monitoring, and potential complications.

Research into what drives the leap from prediabetes to diabetes keeps reinforcing the role of liver health. A meta-analysis found that a high Fatty Liver Index, a score combining waist circumference, BMI, triglycerides, and a liver enzyme, was one of the strongest predictors of progression, with roughly six times the odds of developing diabetes compared with those who had a low score.19PubMed Central. Risk factors for progression to type 2 diabetes in prediabetes: a systematic review and meta-analysis If you have been told your liver enzymes are slightly elevated or that you have fatty liver, take that seriously in the context of blood sugar management.

Damage That Can Already Be There at Diagnosis

One of the more sobering realities of type 2 diabetes is that by the time it is formally diagnosed, it has often been quietly doing harm for years. In a study of people with newly diagnosed type 2 diabetes who underwent thorough screening of the heart, arteries, kidneys, eyes, and nerves, about half already had detectable complications. Roughly 31% had microvascular disease affecting small blood vessels in the eyes, kidneys, or nerves, about 9% had macrovascular disease affecting larger arteries, and another 9% had both.20BMJ Open Diabetes Research & Care. Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features That means nearly one in two newly diagnosed patients already had organ damage they did not know about.

This finding underscores why earlier screening matters. Catching diabetes or prediabetes before complications set in gives you a window to slow or reverse the damage through diet, exercise, weight loss, and, if necessary, medication. Once retinal changes or nerve damage are established, they can be managed but rarely fully reversed.

Emergency Warning Signs

Sometimes diabetes makes itself known through a crisis rather than a gradual symptom. Diabetic ketoacidosis (DKA) occurs when the body runs so short on insulin that it breaks down fat at a dangerous rate, flooding the blood with acids called ketones. Symptoms include nausea, vomiting, abdominal pain, fruity-smelling breath, rapid breathing, and confusion. This is most common in type 1 diabetes but can happen in type 2 under extreme stress.

A related emergency, hyperosmolar hyperglycemic state, involves extremely high blood sugar (sometimes above 600 mg/dL) with severe dehydration but without significant ketone buildup. Both conditions are life-threatening and share enough overlap in symptoms and lab findings that a full clinical evaluation is needed to guide treatment.21Europe PMC. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state If you experience sudden, severe symptoms like uncontrollable vomiting, confusion, or difficulty breathing alongside very high blood sugar, go to an emergency room rather than waiting for a scheduled appointment.

Home Monitoring and Continuous Glucose Devices

For people already diagnosed with diabetes or at high risk, self-monitoring adds a layer of awareness between doctor visits. Traditional finger-stick glucose meters give you a single number at a single moment. They are useful for checking whether you are running high after a meal or low before exercise, but they miss the trends between checks.

Continuous glucose monitors (CGMs) fill that gap. A small sensor inserted under the skin measures glucose in the fluid between your cells, sending readings to your phone or a receiver every few minutes. The trade-off is a time lag: there is a delay of roughly five to twenty minutes before changes in blood sugar show up in the interstitial fluid where the sensor sits, which means CGM readings can be unreliable during rapid fluctuations like right after eating or during intense exercise.22PubMed Central. Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis For general trend tracking, though, they are enormously helpful and have become more accessible to people with type 2 diabetes and even those with prediabetes who want to see how their diet affects their blood sugar in real time.

Emerging Ways to Test Without a Needle

The prospect of diagnosing or monitoring diabetes without a blood draw has been a research goal for decades. The history of glucose measurement itself stretches back centuries. Ancient physicians used taste-testing of urine to detect sweetness, a method that persisted in various forms until chemical techniques emerged in the 1800s and enzyme-based tests came along in the 1900s.23Journal of Clinical Pathology. Historical perspectives in clinical pathology: a history of glucose measurement Modern research has moved well beyond urine strips.

Current non-invasive approaches under investigation include sensors that detect diabetes-related biomarkers in sweat, tears, saliva, and exhaled breath. Breath-based detection is particularly promising because acetone, a byproduct of fat metabolism, is present at elevated levels in the breath of people with poorly controlled diabetes.24PubMed. Breath-based biosensors and system development for noninvasive detection of diabetes: A review None of these methods has replaced standard blood testing for clinical diagnosis yet, and accuracy under real-world conditions remains a hurdle. But they represent a meaningful direction for screening in settings where blood draws are impractical or where fear of needles keeps people from getting tested at all.